You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
*ST宜康(000150.SZ):擬受贈頌陽實業100%股權、其持有藍影醫學9.75%股權及藍韻凱泰30.4348%股權
格隆匯 01-02 14:37

格隆匯12月30日丨*ST宜康(000150.SZ)公佈,公司實際控制人劉紹喜的關聯方汕頭市博承投資有限公司、深圳市達榮輝實業有限公司為支持公司的發展,擬將其持有的深圳市頌陽實業有限公司(“頌陽實業”)100%股權無償捐贈給公司的全資子公司宜華健康醫療產業有限公司(“醫療產業公司”),醫療產業公司無需支付任何對價,並不附任何義務。此次受贈資產完成後,醫療產業公司持有頌陽實業100%股權,頌陽實業將納入上市公司合併報表範圍內。

頌陽實業分別持有深圳藍影醫學科技股份有限公司(“藍影醫學”)9.75%股權、江蘇藍韻凱泰醫療設備有限公司(“藍韻凱泰”)30.4348%股權。

藍影醫學是中國專業、領先的醫學影像解決方案供應商,業務涵蓋放射影像、超聲診斷與5G遠程超聲會診解決方案三大領域。藍影醫學被評為“國家高新技術企業”、“深圳市高新技術企業”。“深圳工程技術研究開發中心”、“質量、服務、誠信AAA級企業”、首批“廣東省教育部產學研結合示範基地”,產品多次入選國家衞計委優秀國產醫療設備遴選。藍影醫學創造了中國醫療器械史的多個“第一”:中國第一台擁有自主知識產權的懸吊DR(醫學數字影像設備)、第一台動態DR、第一台移動DR,中國第一批擁有自主知識產權的彩超診斷系統供應商。目前,DR累積在近3000家醫療機構得到廣泛應用,年銷量穩居中國DR供應商前三甲;超聲診斷系統累積裝機量近萬台。

藍韻凱泰是中國麻醉機、呼吸機老牌專業製造商。公司自1986年成立以來,長期專注麻醉、呼吸領域的產品研製,始終致力於為廣大用户提供品質精良的醫療設備。藍韻凱泰不斷加快現有產品升級換代的速度、推進研製高檔次的麻醉呼吸產品的進程,同時,也為廣大客户提供了包括整體數字化潔淨手術室工程、吊塔,手術牀,無影燈等醫院手術室、重症監護室醫療設備的整體解決方案,地為廣大醫療機構提供、專業、快捷、的服務。

此次受贈頌陽實業100%股權資產不附加任何條件和義務,受贈股權資產完成後,公司將持有頌陽實業100%股權,有利於公司拓展在醫療設備領域的業務,並與公司主營業務產生一定的業務協同效應。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account